ExactAntigen

p300 antibody | antibody review based on formal publications
EP300 antibodies
This is a review about p300 antibodies, based on 36 published articles using p300 antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited p300 antibody.
Sigma-Aldrich    search Sigma-Aldrich EP300 products
ihSigma EP300 antibody was tested in immunohistochemistry by Human Protein Atlas. to the paper
Santa Cruz Biotechnology    search Santa Cruz Biotechnology EP300 products
ip, wbSanta Cruz Biotechnology p300 antibody was used in western blot and immunoprecipitation to demonstrate that neural agrin-dependent reprogramming of myonuclei involves chromatin remodelling, histone hyperacetylation and histone hyperphosphorylation. to the paper
ic, wbSanta Cruz Biotechnology E1A antibody was used in western blot to demonstrate that E4 ORF3 is critical to the replicative success of adenovirus during the IFN-induced antiviral state. to the paper
chipSanta Cruz CBP/p300 antibody was used in ChIP assay to identify novel functional TBP-binding sites and general factor repertoires. to the paper
wbSanta Cruz Biotechnology p300 antibody was used in western blot to study the role of BRMS1 in the metastasis of breast cancer. to the paper
wbSanta Cruz Biotechnology rabbit anti-p300 (C-20) was used in western blot to demonstrate p300 modulating ATF4 stability and transcriptional activity independently of its acetyltransferase domain. to the paper
wbSanta Cruz Biotechnology mouse anti-p300 was used in western blot for p300 as a control to assess the quality of the fractionation of nuclear and cytoplasmic extracts from male and female genital ridges from 11. 5 dpc mouse embryos. to the paper
chipSanta Cruz Biotechnology anti-p300 (C-20) was used in CHIP assay to determine whether Hic-5/ARA55 interacts with other coactivator proteins at glucocorticoid-responsive promoters in A1–2 cells derived from the T47D human mammary carcinoma cells line. to the paper
ipSCBT p300 (N-15) antibody was used in ChiP assay to investigate the regulation of ER alpha proteolysis and transcription. to the paper
ipSCBT p300 antibody (N-15) was used in ChIP assays to study aryl hydrocarbon receptor-mediated transcription in MCF-7 human breast carcinoma, T47D breast carcinoma cells, and HuH7 human liver carcinoma cells. to the paper
emsaSanta Cruz Biotechnology anti-p300 antibody was used in EMSA to study the regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling. to the paper
wbSanta Cruz Biotechnology anti-p300 antibody was used in western blot to detect p300 in TSA-treated MIA PaCa-2 cells. to the paper
wbSanta Cruz Biotechnology rabbit anti-p300 (C-20) polyclonal antibody (epitope mapping at the C-terminus of p300 of human origin) was used to study Ciglitazone induced cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells. to the paper
ip, wbSanta Cruz Biotechnology anti-p300 antibody was used in western blot, immunoprecipitation to study that notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. to the paper
chipSantz mouse antihuman p300 antibody was used in chromatin immunoprecipitation (ChIP) to study the affect of ER transcription factor cross talk on a genome-wide scale in Breast Cancer. to the paper
chipSanta Cruz Biotechnology antibody against p300 (N-15) was used in chip assay to examine the dynamic association of coactivator p300 with the ERalpha-responsive promoters in human T47D cells. to the paper
ip, wbSanta Cruz anti-p300 antibody was used in western blot and immunoprecipitation to study the acetylation of the human DNA glycosylase NEIL2 and inhibition of its activity. to the paper
wbSanta Cruz anti-p300 was used in western blot to detect p300 levels in human HEK293T cells. to the paper
chip, ip, wbSanta Cruz Biotechnology rabbit polyclonal anti-human p300 antibody was used in western blot, immunoprecipitation and ChIP assay to study p300 in RAW 264.7 cells with wt p300 or p300 HAT deletion mutant transfection. to the paper
ih, ip, wbSanta Cruz Biotechnology anti-p300 antibody was used in western blot, immunoprecipitation and immunohistochemistry to detect p300 in HeLa cells. to the paper
wbSanta Cruz Biotechnology polyclonal anti-p300 antibody was used in western blot to provide biochemical and genetic evidence to show that the HATs p300, CBP, and PCAF are regulators of E2A activity in B lymphocytes. to the paper
ic, wbSanta Cruz Biotechnology rabbit anti-p300 was used in western blot and immunocytochemistry to study that mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. to the paper
wbSanta Cruz Biotechnology p300 polyclonal antibody that does not cross-react with cAMP-response element-binding protein (CREB) -binding protein (N-15) was used in western blot to study the function of the HMG-I/Y-related protein p8 to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter by binding to p300 and Pax2 trans-activation domain-interacting protein (PTIP). to the paper
wbSanta Cruz Biotechnology anti-p300 antibody was used in human HEK293 cells and in western blot to study the role for the interaction of PIMT with transcriptional coactivators CBP, p300, and PBP in transcriptional regulation. to the paper
wbSanta Cruz Biotechnology anti-human p300 antibody was used in western blot to study the different function of protein kinase A and glycogen synthase kinase-3b for the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D. to the paper
chipSanta Cruz Biotechnology anti-p300 antibody was used in ChIP assay to study the regulation of adipocyte specificity of resistin gene expression. to the paper
wbSanta Cruz Biotechnology goat anti-p300 antibody was used in western blot to study the role of deltex-1 as a transcriptional regulator downstream of the notch receptor. to the paper
ipSanta Cruz Biotechnology rabbit polyclonal anti-p300 antibody was used in immunoprecipitation to study the Interaction of a novel zinc finger protein TReP-132 with CBP/p300 to regulate human CYP11A1 gene expression. to the paper
ip, wbSanta Cruz Biotechnology anti-p300 polyclonal antibody was used in western blot and immunoprecipitation to study the down-regulation of Msx1 promoter through recruiting histone deacetylase by Msx3 protein. to the paper
BD Biosciences    search BD Biosciences EP300 products
ip, wbPharmingen anti-p300 monoclonal antibody (NM11) was used in western blot and immunoprecipitation to study the effects of MAPK signaling on the activity of hypoxia-inducible factors by promoting the formation of the HIF-p300/CBP complex and by modulating the transactivation activity of p300/CBP. to the paper
EMD Biosciences    search EMD Biosciences EP300 products
wbOncogene anti-p300 was used in western blot to study a role for STAG/Scc3 in transcriptional regulation by cohesins. to the paper
icCalbiochem monoclonal anti-p300 antibody was used in human Calu-6 cells and in immunocytochemistry to study the function of ZNF265. to the paper
Invitrogen    search Invitrogen EP300 products
ihZymed EP300 antibody was tested in immunohistochemistry by HPA (HPA004112) . to the paper
ipZymed Laboratories anti-p300 monoclonal antibody was used in immunoprecipitation to study transforming growth factor-beta signaling. to the paper
Millipore    search Millipore EP300 products
ip, wbUpstate Biotechnology anti-p300 antibody was used in western blot and immunoprecipitation to detect p300 in HeLa cells. to the paper
wbUpstate Biotechnology anti-p300 antibody was used in western blot to study the molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. to the paper
chip, ip, wbUpstate Biotechnology E1a antibody was used in western blot,immunoprecipitation and ChIP assay to study the regulation of the FGF-4 gene. to the paper
wbUpstate Biotechnology anti-p300 antibody was used in western blot to study the different function of protein kinase A and glycogen synthase kinase-3b for the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D. to the paper
LAB VISION
wbLab Vision p300/CBP antibody was tested in western blot by Abminer . to the paper
Articles Reviewed
1:Sergey Denissov et al. Identification of novel functional TBP-binding sites and general factor repertoires. 2007
2:Amanda J Ullman et al. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. 2007
3:Aymeric Ravel-Chapuis et al. Postsynaptic chromatin is under neural control at the neuromuscular junction. 2007
4:Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006
5:Anja Persson et al. A human protein atlas based on antibody proteomics. 2006
6:M D Heitzer et al. Mechanism of action of Hic-5/androgen receptor activator 55, a LIM domain-containing nuclear receptor coactivator. 2006
7:Yuan Liu et al. Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. 2006
8:Christopher C Valley et al. Differential regulation of estrogen-inducible proteolysis and transcription by the estrogen receptor alpha N terminus. 2005
9:Fei Chen et al. Ciglitazone induces early cellular proliferation and NF-kappaB transcriptional activity in colon cancer cells through p65 phosphorylation. 2005
10:Weiqi Huang et al. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex. 2005
11:Irina Lassot et al. p300 modulates ATF4 stability and transcriptional activity independently of its acetyltransferase domain. 2005
12:Shunbin Ning et al. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling. 2005
13:David G DeNardo et al. Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes. 2005
14:Eri Ishiko et al. Notch signals inhibit the development of erythroid/megakaryocytic cells by suppressing GATA-1 activity through the induction of HES1. 2005
15:Jason Matthews et al. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. 2005
16:Laurie Thevenet et al. NHERF2/SIP-1 interacts with mouse SRY via a different mechanism than human SRY. 2005
17:Enrique Lara-Pezzi et al. Evidence of a transcriptional co-activator function of cohesin STAG/SA/Scc3. 2004
18:Sarah E Aiyar et al. Attenuation of estrogen receptor alpha-mediated transcription through estrogen-stimulated recruitment of a negative elongation factor. 2004
19:Maria Carla Motta et al. Mammalian SIRT1 represses forkhead transcription factors. 2004
20:Kishor K Bhakat et al. Acetylation of the human DNA glycosylase NEIL2 and inhibition of its activity. 2004
21:Nianli Sang et al. MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. 2003
22:Kiyoshi Higashi et al. Interferon-gamma interferes with transforming growth factor-beta signaling through direct interaction of YB-1 with Smad3. 2003
23:Rui Hong et al. The human proliferating Cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression. 2003
24:Tamara Nowling et al. The co-activator p300 associates physically with and can mediate the action of the distal enhancer of the FGF-4 gene. 2003
25:Dmitri Wiederschain et al. Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL. 2003
26:Wu-Guo Deng et al. Regulation of inducible nitric oxide synthase expression by p300 and p50 acetylation. 2003
27:Curtis Bradney et al. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. 2003
28:Mate Tolnay et al. Protein kinase A enhances, whereas glycogen synthase kinase-3 beta inhibits, the activity of the exon 2-encoded transactivator domain of heterogeneous nuclear ribonucleoprotein D in a hierarchical fashion. 2002
29:Parimal Misra et al. Interaction of PIMT with transcriptional coactivators CBP, p300, and PBP differential role in transcriptional regulation. 2002
30:Helen B Hartman et al. Mechanisms regulating adipocyte expression of resistin. 2002
31:Christy J Fryer et al. Mastermind mediates chromatin-specific transcription and turnover of the Notch enhancer complex. 2002
32:Albrecht Hoffmeister et al. The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation domain-interacting protein to regulate the trans-activation activity of the Pax2A and Pax2B transcription factors on the glucagon gene promoter. 2002
33:N Yamamoto et al. Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor. 2001
34:D J Adams et al. ZNF265--a novel spliceosomal protein able to induce alternative splicing. 2001
35:R Mehra-Chaudhary et al. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter. 2001
36:F Gizard et al. A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate human CYP11A1 gene expression. 2001


2008©ExactAntigen home | browse | about